Literature DB >> 2343853

Oral contraceptive use and the risk of myocardial infarction.

L Rosenberg1, J R Palmer, S M Lesko, S Shapiro.   

Abstract

The relation of oral contraceptive use to the risk of myocardial infarction was assessed in a hospital-based case-control study of women aged 25-64 years conducted from 1985 to 1988 in New England; 910 women with first myocardial infarctions were compared with 1,760 control women. Oral contraceptive use, after discontinuation, was not associated with an increased risk of myocardial infarction, whether use had ceased in the distant past or more recently. The overall relative risk estimate for women who had used oral contraceptives in the past for at least 5 years compared with nonusers was 1.1 (95% confidence interval 0.8-1.5) after allowance for confounding factors. Past use was not associated with risk in any age group, in subgroups of women with predisposing factors, or in women at low risk because of the absence of predisposing factors. The results suggest that long-term oral contraceptive use, after discontinuation, does not influence the risk of myocardial infarction. There were few current users and the results for current use were inconclusive: for premenopausal women who had used oral contraceptives in the previous month relative to those who had not, the age-adjusted relative risk estimate was 1.1 (95% confidence interval 0.4-3.1).

Entities:  

Keywords:  Age Factors; Americas; Behavior; Case Studies; Contraception; Contraceptive Methods--side effects; Control Groups; Demographic Factors; Developed Countries; Diseases; Family Planning; Heart Diseases; Hypertension; Longterm Effects; Myocardial Infarction; North America; Northern America; Oral Contraceptives--side effects; Population; Population At Risk; Population Characteristics; Population Dynamics; Research Methodology; Smoking; Studies; Time Factors; United States; Vascular Diseases

Mesh:

Substances:

Year:  1990        PMID: 2343853     DOI: 10.1093/oxfordjournals.aje.a115592

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  5 in total

Review 1.  Benefits and risks of third-generation oral contraceptives.

Authors:  E S Leblanc; A Laws
Journal:  J Gen Intern Med       Date:  1999-10       Impact factor: 5.128

Review 2.  Using epidemiological data to guide clinical practice: review of studies on cardiovascular disease and use of combined oral contraceptives.

Authors:  P C Hannaford; V Owen-Smith
Journal:  BMJ       Date:  1998-03-28

3.  Oral contraceptives and myocardial infarction: results of the MICA case-control study.

Authors:  N Dunn; M Thorogood; B Faragher; L de Caestecker; T M MacDonald; C McCollum; S Thomas; R Mann
Journal:  BMJ       Date:  1999-06-12

Review 4.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 5.  Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.

Authors:  Rachel E J Roach; Frans M Helmerhorst; Willem M Lijfering; Theo Stijnen; Ale Algra; Olaf M Dekkers
Journal:  Cochrane Database Syst Rev       Date:  2015-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.